Integrated Islet Distribution Program supports access to human pancreatic islets for diabetes research
Official title: Integrated Islet Distribution Program (U24) - 2021
Funded at Beckman Research Institute/city of Hope · NIH-11605381 · Data updated 2026-11-12
This grant helps provide researchers with human pancreatic islets and related tissues to study diabetes, aiming to accelerate better understanding and treatments for adults with diabetes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beckman Research Institute/city of Hope NIH-funded |
| Lab location | 1 site (Duarte, United States) |
| Project start | September 30, 2012 |
| Project end | July 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $2,885,999 |
| NIH project number | 5U24DK098085-08 |
| Project ID | NIH-11605381 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers and laboratories studying diabetes who need human islets and related tissues for their experiments.
✕Less likely to help
This grant does not directly involve patient participation; it supports researchers' access to materials.
What this research studies
The IIDP Coordinating Center at City of Hope will continue to supply high-quality human islets and ancillary tissues to researchers worldwide. It supports the qualification of islet isolation labs, tracks demand, and manages access through an advanced electronic allocation system. This renewal emphasizes coordination with multiple partner labs, pilot studies, and review processes to ensure researchers receive reliable materials for diabetes research. The work directly involves human tissues to advance knowledge about diabetes pathophysiology and potential therapies.
Why it matters
Potential benefit: Access to human islets and related tissues could accelerate discoveries that improve prevention and treatment of diabetes.
How similar studies have gone: The program has a long history of supporting numerous studies and publications using human islets, indicating proven utility.
Where this research is happening
-
Beckman Research Institute/city of Hope
Duarte, United States Active
Researchers
- Principal investigator: Niland, Joyce Carol — Beckman Research Institute/city of Hope
- Study coordinator: Niland, Joyce Carol
Related research
Other NIH-funded projects on the same topics.
-
Targeting the protein-assembly that drives AML growth
Aiming to slow or stop acute myeloid leukemia by blocking how cancer cells make proteins.
-
Metformin for reversing accelerated aging in young adults with metabolic health issues
A practical plan to use metformin to help 18- to 35-year-olds with insulin resistance improve metabolic health and slow aging.
-
PIN1-targeted therapy for pancreatic cancer
A team is developing new PIN1 inhibitors to treat pancreatic cancer that tends to resist current therapies.
-
DNA mismatch repair defects and anti-tumor immunity in cancer
Researchers are studying how defects in a DNA repair system affect the body’s immune response to tumors, to improve cancer treatments that use the immune system.
-
Understanding how skin cancer-associated fibroblasts affect immune detection in early mycosis fungoides
This grant investigates how certain skin cells in early mycosis fungoides might help the cancer hide from the immune system, with findings aiming to improve future patient care.
-
Small-molecule and biologic treatments for glioblastoma using targeted brain delivery
A new approach aims to use FPS-ZM1 to shrink brain swelling and support immunotherapy for glioblastoma, potentially helping patients recover after surgery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.